News

@DermTimesNow
dermatologytimes.com > view > raising-the-bar-for-hs-outcomes-with-barry-resnik-md

Raising the Bar for HS Outcomes With Barry Resnik, MD

Raising the Bar for HS Outcomes With Barry Resnik, MD1+ hour, 37+ min ago   (229+ words) Modern HS management prioritizes restoration of function and quality of life, not just reduction in lesion counts, according to Resnik. Functional outcomes, rather than lesion counts alone, were highlighted as critical markers of success. Patients are asked early what activities…...

@DermTimesNow
dermatologytimes.com > view > when-innovation-meets-insurance-barriers-with-lisa-swanson-md

When Innovation Meets Insurance Barriers With Lisa Swanson, MD

When Innovation Meets Insurance Barriers With Lisa Swanson, MD3+ hour, 37+ min ago   (508+ words) When Innovation Meets Insurance Barriers With Lisa Swanson, MD'Dermatology Times For decades, clinicians caring for patients with rare genetic skin diseases have had few therapeutic tools beyond symptom management. In a recent Dermatology Times interview at the 2026 Masters of Pediatric…...

@DermTimesNow
dermatologytimes.com > view > glp-1s-and-skin-health-clinical-pearls-from-gold-and-lal

GLP-1s and Skin Health: Clinical Pearls From Gold and Lal

GLP-1s and Skin Health: Clinical Pearls From Gold and Lal14+ hour, 34+ min ago   (227+ words) GLP-1 therapies represent a paradigm shift requiring dermatology to integrate metabolic, medical, and aesthetic care. The aesthetic consequences'popularized by terms like "Ozempic face'are more clinically framed as facial lipoatrophy and soft tissue redistribution. Rapid fat loss unmasks volume deficits in…...

@DermTimesNow
dermatologytimes.com > view > mona-shahriari-md-faad-on-ox40-targeted-therapy-in-ad

Mona Shahriari, MD, FAAD, on OX40-Targeted Therapy in AD

Mona Shahriari, MD, FAAD, on OX40-Targeted Therapy in AD1+ day, 2+ hour ago   (676+ words) Mona Shahriari, MD, FAAD, on OX40-Targeted Therapy in AD'Dermatology Times Mona Shahriari, MD, FAAD, on OX40-Targeted Therapy in AD - OX40-directed agents intervene upstream of cytokine signaling by modulating antigen-specific T cells, potentially preventing pathogenic memory T-cell persistence and enabling durable…...

@DermTimesNow
dermatologytimes.com > view > chronic-sd-requires-mechanism-based-management

Chronic SD Requires Mechanism-Based Management

Chronic SD Requires Mechanism-Based Management1+ day, 3+ hour ago   (514+ words) Chronic SD Requires Mechanism-Based Management'Dermatology Times Chronic SD Requires Mechanism-Based Management - Inflammation is increasingly viewed as the dominant driver of seborrheic dermatitis, supporting chronic, mechanism-based management analogous to other relapsing inflammatory dermatoses. - Long-term topical corticosteroid exposure is constrained by cumulative…...

@DermTimesNow
dermatologytimes.com > view > rethinking-menopause-related-skin-changes-in-clinical-practice

Rethinking Menopause-Related Skin Changes in Clinical Practice

Rethinking Menopause-Related Skin Changes in Clinical Practice1+ day, 4+ hour ago   (479+ words) Rethinking Menopause-Related Skin Changes in Clinical Practice'Dermatology Times Hormonal changes across the lifespan of women has become an increasingly relevant topic in dermatology, particularly as patients present with concerns that extend beyond traditional aesthetic complaints. Hair thinning, xerosis, impaired barrier…...

@DermTimesNow
dermatologytimes.com > view > less-is-more-a-practical-approach-to-tween-skin-care

Less Is More: A Practical Approach to Tween Skin Care

Less Is More: A Practical Approach to Tween Skin Care1+ day, 6+ hour ago   (241+ words) At MOPD 2026, Lisa Swanson, MD, urges fungal cultures amid terbinafine resistance and warns attendees about risky kids" skin care trends. Swanson opened with a concern many clinicians are now encountering firsthand: "Resistance is everywhere, and this is a relatively new…...

@DermTimesNow
dermatologytimes.com > view > day-2-recap-south-beach-symposium-2026

Day 2 Recap: South Beach Symposium 2026

Day 2 Recap: South Beach Symposium 20261+ day, 14+ hour ago   (85+ words) Catch up on coverage from the second day of South Beach Symposium 2026. David Cotter, MD, PhD, underscored the importance of incorporating quality-of-life and mental health measures into psoriasis clinical trials. At SBS 2026, Karan Lal, MD, and Mohammad Goldust, MD, reveal…...

@DermTimesNow
dermatologytimes.com > view > ablon-s-alopecia-and-aesthetic-best-practices

Ablon's Alopecia and Aesthetic Best Practices

Ablon's Alopecia and Aesthetic Best Practices1+ day, 18+ hour ago   (278+ words) Ablon noted that questions about hair loss are among the most common she receives. She emphasized that accurate diagnosis is the foundation of effective treatment. "The first thing you wanna do is make sure you diagnose the type of alopecia…...

@DermTimesNow
dermatologytimes.com > view > balancing-molecular-tools-with-clinical-judgment

Balancing Molecular Tools With Clinical Judgment

Balancing Molecular Tools With Clinical Judgment1+ day, 20+ hour ago   (579+ words) Balancing Molecular Tools With Clinical Judgment'Dermatology Times Genetic testing has transformed pediatric dermatology, offering unprecedented diagnostic clarity for complex and rare conditions. Yet Antonio Torrelo, MD, emphasized at South Beach Symposium and Masters of Pediatric Dermatology 2026 that genetics does not…...